ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Revenue growth (%)

TERUMO CORPORATION (4543)

Market cap
¥3.22T
P/E ratio
23.6x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202512.4+0.08%
Mar 31, 202412.4-25.45%
Mar 31, 202316.6+14.07%
Mar 31, 202214.6-709.62%
Mar 31, 2021-2.4-148.68%
Mar 31, 20204.9+146.73%
Mar 31, 20192-86.10%
Mar 31, 201814.3-791.79%
Mar 31, 2017-2.1-128.51%
Mar 31, 20167.3+53.16%
Mar 31, 20154.7-70.69%
Mar 31, 201416.2+300.25%
Mar 31, 20134

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat